ZELTIQ Gets FDA Nod To Treat Submental Fat With Coolsculpting Procedure

(RTTNews) - ZELTIQ Aesthetics, Inc. (ZLTQ), a medical technology company, Wednesday said it received an expanded clearance from the U.S. Food and Drug Administration paving the way for introduction of the new, CoolMini applicator.

The applicator is designed to treat smaller pockets of fat, including the submental, or chin fat area, more commonly referred to as the double chin.

The CoolSculpting procedure has demonstrated in over 50 published clinical articles and 4,000 clinical trial patients to non-invasively and consistently reduce unwanted fat and the procedure has been successfully used in over two million treatments so far.

The new CoolMini applicator is designed for small volume areas of fat. Its size, shape and curvature are designed to comfortably fit these small, problem areas.

Patients may see results as early as three weeks, with the most dramatic results generally observed 1-3 months following treatment.